Cooper Energy

The London Company initiated a position in The Cooper Companies citing its CooperVision and CooperSurgical franchises, oligopolistic contact‑lens market share, high customer switching costs and above‑market growth in specialty lenses. The firm noted margins currently lag peers due to a multi‑year investment cycle but see significant expansion as capex moderates, with activist involvement and recent insider buying providing catalysts. The move came amid a volatile Q1 where the strategy underperformed the Russell 2500 due to sector and stock selection differences; COO closed at $67.51 on June 11 with strong one‑month gains. » Más en finance.yahoo.com

The Cooper Companies’ stock rose about 8.1% in morning trading after Q2 2026 results that beat revenue and earnings expectations. Adjusted EPS was $1.21 (expectation $1.10) and revenue was $1.08bn (expectation $1.05bn), with revenue up 5% organically and 8% overall, marking a quarterly record. Management reported strong interest in CooperSurgical as part of a strategic review and announced more aggressive share buybacks; CEO Albert White also purchased 10,000 shares, seen as a vote of confidence. » Más en de.investing.com

Sustainable Growth Advisers named The Cooper Companies a top contributor in Q4 2025 after the firm reported better operating results and announced shareholder‑friendly developments. CooperVision eased supply constraints for premium daily silicone hydrogel lenses, won new private‑label contracts in the US and Europe, and advanced myopia‑control and multifocal platforms, while CooperSurgical showed sequential improvement. The stock closed at $81.48 on Feb. 9, 2026 with a market cap of $16.199 billion and is down 12.81% over the past 52 weeks. » Más en finance.yahoo.com